Garwood Medical Devices Overview
- Founded
-
2014
- Status
-
Private
- Employees
-
13
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$7M
- Investors
-
3
Garwood Medical Devices General Information
Description
Developer of an electronic medical device and treatment intended to eliminate the need for follow-up surgeries. The company's device is currently under investigation to study the elimination of biofilm infections on prosthetic knee implants during early intervention procedures while maintaining the current standard of care, enabling medical practitioners to treat implant infections in a better and more effective manner.
Contact Information
Website
www.garwoodmedicaldevices.com
Formerly Known As
Enermed
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Primary Office
- 665 Northland Avenue
- Buffalo, NY 14211
- United States
+1 (716) 000-0000
Garwood Medical Devices Timeline
Garwood Medical Devices Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series C) | 13-Oct-2020 | $7M | 000.00 | 0000 | Completed | Pre-Clinical Trials |
| 3. Seed Round | 30-Nov-2019 | 00.00 | 00.00 | 000.00 | Completed | Pre-Clinical Trials |
| 2. Early Stage VC | $200K | $3.8M | Completed | Pre-Clinical Trials | ||
| 1. Seed Round | 30-Sep-2016 | $3.6M | $3.6M | 000.00 | Completed | Pre-Clinical Trials |
Garwood Medical Devices Patents
Garwood Medical Devices Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20210370052-A1 | Dental implant and system for treatment | Pending | 27-May-2020 | 0000000000 | |
| EP-3976859-A1 | Autonomous hydrogen evolution reaction threshold detection method and device | Pending | 03-Jun-2019 | 00000000 | |
| CA-3138562-A1 | Autonomous hydrogen evolution reaction threshold detection method and device | Pending | 03-Jun-2019 | 00000000 | |
| AU-2020287598-A8 | Autonomous hydrogen evolution reaction threshold detection method and device | Pending | 03-Jun-2019 | 00000000 | |
| AU-2020287598-A1 | Autonomous hydrogen evolution reaction threshold detection method and device | Pending | 03-Jun-2019 | C25F1/00 |
Garwood Medical Devices Executive Team (5)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Wayne Bacon | Co-Founder, Chief Executive Officer, President & Board Member | ||
| Brian Peterson | Co-Founder & Board Member | ||
| Norman Murray | Advisor | ||
| William Joyce | Advisor |
Garwood Medical Devices Board Members (2)
| Name | Representing | Role | Since |
|---|---|---|---|
| Brian Peterson | Garwood Medical Devices | Co-Founder & Board Member | 000 0000 |
| Wayne Bacon | Garwood Medical Devices | Co-Founder, Chief Executive Officer, President & Board Member | 000 0000 |
Garwood Medical Devices Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Garwood Medical Devices Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Murray Capital | Family Office | Minority | 000 0000 | 000000 0 | |
| WNY Impact Investment Fund | PE/Buyout | Minority | 000 0000 | 000000 0 | |
| Norman Murray | Angel (individual) | Minority | 000 0000 | 000000 0 |